| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 7, 2023 | Dec 8, 2023 | SAB Biotherapeutics, Inc. | CEO | Buy | 47.5 | +1,740 | 0.03% | ✗ | $1.5K |
| Sep 7, 2022 | Sep 8, 2022 | SAB Biotherapeutics, Inc. | CEO | Buy | 61.3 | +14,000 | 0.27% | ✗ | $10.3K |